The C allele of the GNB3 C825T polymorphism of the G protein beta 3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours
Carriers of the C allele of the common C825T polymorphism in the GNB3 gene of the G protein have been associated with the development of follicular thyroid adenomas. Since the C allele of this polymorphism is related to a lower signalling capacity, it was speculated whether the C825T polymorphism ma...
Gespeichert in:
Veröffentlicht in: | The Journal of pathology 2007-01, Vol.211 (1), p.60-66 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 66 |
---|---|
container_issue | 1 |
container_start_page | 60 |
container_title | The Journal of pathology |
container_volume | 211 |
creator | Sheu, S-Y Handke, S Broecker-Preuss, M Goerges, R Frey, Uh Ensinger, C Oefner, D Farid, Nr Siffert, W Schmid, Kw |
description | Carriers of the C allele of the common C825T polymorphism in the GNB3 gene of the G protein have been associated with the development of follicular thyroid adenomas. Since the C allele of this polymorphism is related to a lower signalling capacity, it was speculated whether the C825T polymorphism may play a particular role in oncocytic thyroid tumours, which are recognized for their reduced ability to synthesize thyroid-specific proteins and hormones, although they possess an intact thyroid-stimulating hormone receptor-adenylyl cyclase system. Using pyrosequencing, both the genotype distribution and the allele frequency of the C825T polymorphism were investigated in a series of 104 patients with oncocytic thyroid tumours of follicular cell origin [58 adenomas, 41 follicular thyroid carcinomas (FTCs), and five papillary thyroid carcinomas (PTCs)]; the results were compared with those obtained from 321 age and gender- matched healthy blood donors and a series of 327 non-oncocytic thyroid tumours of follicular cell origin (119 adenomas, 80 FTCs, and 186 PTCs). Analysis of the genotype distribution (comparing oncocytic with non-oncocytic tumours of the present series) revealed a significantly increased odds ratio (OR) for CC versus TT (OR = 4.22; p = 0.011) and CC versus CT (OR = 1.62; p = 0.049) carriers to develop an oncocytic thyroid tumour; ORs to develop an oncocytic thyroid tumour were also increased comparing the genotype distribution between the group of oncocytic tumours and healthy controls for CC versus TT (OR = 3.73; p = 0.017) and CC versus all T carriers (OR = 1.56; p = 0.034). Oncocytic thyroid tumours as a group showed a statistically significant increase of the C-allele frequency when compared with all non-oncocytic tumours (p = 0.0039) as well as healthy blood donors (p = 0.017). The results strongly suggest that the C allele of the GNB3 C825T polymorphism of the G protein beta 3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours. This polymorphism may thus be considered a (co)factor favouring the development of oncocytic thyroid tumours, although the biological mechanism(s) underlying this association remain obscure. |
doi_str_mv | 10.1002/path.2084 |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_19498157</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19498157</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_194981573</originalsourceid><addsrcrecordid>eNqNjjtPxDAQhF2AxPEo-Adb0d3hvHRJS8Sjokp_8jkbxeB4g3cNys_hnxIQoqYazXyj0Sh1neldpnV-OxsZd7muyxO1WX2-Lcpsf6bOmV-01k1TVRv12Y0ILRjv0SPQALL6x-e7Ato6rzqYyS8TxXl0PP1hmCMJugBHFAPFltMxBSfgGAwzWWcEe_hwMoIJ4IKNaHhNouNXGCj-rPT4jp7mCYN8D1OwZBdxdoVLJNeDpIlS5Et1OhjPePWrF-rm4b5rn7bribeELIfJsUXvTUBKfMiasqmzal_8u_gF9-liTQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19498157</pqid></control><display><type>article</type><title>The C allele of the GNB3 C825T polymorphism of the G protein beta 3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours</title><source>Access via Wiley Online Library</source><creator>Sheu, S-Y ; Handke, S ; Broecker-Preuss, M ; Goerges, R ; Frey, Uh ; Ensinger, C ; Oefner, D ; Farid, Nr ; Siffert, W ; Schmid, Kw</creator><creatorcontrib>Sheu, S-Y ; Handke, S ; Broecker-Preuss, M ; Goerges, R ; Frey, Uh ; Ensinger, C ; Oefner, D ; Farid, Nr ; Siffert, W ; Schmid, Kw</creatorcontrib><description>Carriers of the C allele of the common C825T polymorphism in the GNB3 gene of the G protein have been associated with the development of follicular thyroid adenomas. Since the C allele of this polymorphism is related to a lower signalling capacity, it was speculated whether the C825T polymorphism may play a particular role in oncocytic thyroid tumours, which are recognized for their reduced ability to synthesize thyroid-specific proteins and hormones, although they possess an intact thyroid-stimulating hormone receptor-adenylyl cyclase system. Using pyrosequencing, both the genotype distribution and the allele frequency of the C825T polymorphism were investigated in a series of 104 patients with oncocytic thyroid tumours of follicular cell origin [58 adenomas, 41 follicular thyroid carcinomas (FTCs), and five papillary thyroid carcinomas (PTCs)]; the results were compared with those obtained from 321 age and gender- matched healthy blood donors and a series of 327 non-oncocytic thyroid tumours of follicular cell origin (119 adenomas, 80 FTCs, and 186 PTCs). Analysis of the genotype distribution (comparing oncocytic with non-oncocytic tumours of the present series) revealed a significantly increased odds ratio (OR) for CC versus TT (OR = 4.22; p = 0.011) and CC versus CT (OR = 1.62; p = 0.049) carriers to develop an oncocytic thyroid tumour; ORs to develop an oncocytic thyroid tumour were also increased comparing the genotype distribution between the group of oncocytic tumours and healthy controls for CC versus TT (OR = 3.73; p = 0.017) and CC versus all T carriers (OR = 1.56; p = 0.034). Oncocytic thyroid tumours as a group showed a statistically significant increase of the C-allele frequency when compared with all non-oncocytic tumours (p = 0.0039) as well as healthy blood donors (p = 0.017). The results strongly suggest that the C allele of the GNB3 C825T polymorphism of the G protein beta 3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours. This polymorphism may thus be considered a (co)factor favouring the development of oncocytic thyroid tumours, although the biological mechanism(s) underlying this association remain obscure.</description><identifier>ISSN: 0022-3417</identifier><identifier>DOI: 10.1002/path.2084</identifier><language>eng</language><ispartof>The Journal of pathology, 2007-01, Vol.211 (1), p.60-66</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Sheu, S-Y</creatorcontrib><creatorcontrib>Handke, S</creatorcontrib><creatorcontrib>Broecker-Preuss, M</creatorcontrib><creatorcontrib>Goerges, R</creatorcontrib><creatorcontrib>Frey, Uh</creatorcontrib><creatorcontrib>Ensinger, C</creatorcontrib><creatorcontrib>Oefner, D</creatorcontrib><creatorcontrib>Farid, Nr</creatorcontrib><creatorcontrib>Siffert, W</creatorcontrib><creatorcontrib>Schmid, Kw</creatorcontrib><title>The C allele of the GNB3 C825T polymorphism of the G protein beta 3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours</title><title>The Journal of pathology</title><description>Carriers of the C allele of the common C825T polymorphism in the GNB3 gene of the G protein have been associated with the development of follicular thyroid adenomas. Since the C allele of this polymorphism is related to a lower signalling capacity, it was speculated whether the C825T polymorphism may play a particular role in oncocytic thyroid tumours, which are recognized for their reduced ability to synthesize thyroid-specific proteins and hormones, although they possess an intact thyroid-stimulating hormone receptor-adenylyl cyclase system. Using pyrosequencing, both the genotype distribution and the allele frequency of the C825T polymorphism were investigated in a series of 104 patients with oncocytic thyroid tumours of follicular cell origin [58 adenomas, 41 follicular thyroid carcinomas (FTCs), and five papillary thyroid carcinomas (PTCs)]; the results were compared with those obtained from 321 age and gender- matched healthy blood donors and a series of 327 non-oncocytic thyroid tumours of follicular cell origin (119 adenomas, 80 FTCs, and 186 PTCs). Analysis of the genotype distribution (comparing oncocytic with non-oncocytic tumours of the present series) revealed a significantly increased odds ratio (OR) for CC versus TT (OR = 4.22; p = 0.011) and CC versus CT (OR = 1.62; p = 0.049) carriers to develop an oncocytic thyroid tumour; ORs to develop an oncocytic thyroid tumour were also increased comparing the genotype distribution between the group of oncocytic tumours and healthy controls for CC versus TT (OR = 3.73; p = 0.017) and CC versus all T carriers (OR = 1.56; p = 0.034). Oncocytic thyroid tumours as a group showed a statistically significant increase of the C-allele frequency when compared with all non-oncocytic tumours (p = 0.0039) as well as healthy blood donors (p = 0.017). The results strongly suggest that the C allele of the GNB3 C825T polymorphism of the G protein beta 3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours. This polymorphism may thus be considered a (co)factor favouring the development of oncocytic thyroid tumours, although the biological mechanism(s) underlying this association remain obscure.</description><issn>0022-3417</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqNjjtPxDAQhF2AxPEo-Adb0d3hvHRJS8Sjokp_8jkbxeB4g3cNys_hnxIQoqYazXyj0Sh1neldpnV-OxsZd7muyxO1WX2-Lcpsf6bOmV-01k1TVRv12Y0ILRjv0SPQALL6x-e7Ato6rzqYyS8TxXl0PP1hmCMJugBHFAPFltMxBSfgGAwzWWcEe_hwMoIJ4IKNaHhNouNXGCj-rPT4jp7mCYN8D1OwZBdxdoVLJNeDpIlS5Et1OhjPePWrF-rm4b5rn7bribeELIfJsUXvTUBKfMiasqmzal_8u_gF9-liTQ</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Sheu, S-Y</creator><creator>Handke, S</creator><creator>Broecker-Preuss, M</creator><creator>Goerges, R</creator><creator>Frey, Uh</creator><creator>Ensinger, C</creator><creator>Oefner, D</creator><creator>Farid, Nr</creator><creator>Siffert, W</creator><creator>Schmid, Kw</creator><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20070101</creationdate><title>The C allele of the GNB3 C825T polymorphism of the G protein beta 3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours</title><author>Sheu, S-Y ; Handke, S ; Broecker-Preuss, M ; Goerges, R ; Frey, Uh ; Ensinger, C ; Oefner, D ; Farid, Nr ; Siffert, W ; Schmid, Kw</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_194981573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sheu, S-Y</creatorcontrib><creatorcontrib>Handke, S</creatorcontrib><creatorcontrib>Broecker-Preuss, M</creatorcontrib><creatorcontrib>Goerges, R</creatorcontrib><creatorcontrib>Frey, Uh</creatorcontrib><creatorcontrib>Ensinger, C</creatorcontrib><creatorcontrib>Oefner, D</creatorcontrib><creatorcontrib>Farid, Nr</creatorcontrib><creatorcontrib>Siffert, W</creatorcontrib><creatorcontrib>Schmid, Kw</creatorcontrib><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>The Journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sheu, S-Y</au><au>Handke, S</au><au>Broecker-Preuss, M</au><au>Goerges, R</au><au>Frey, Uh</au><au>Ensinger, C</au><au>Oefner, D</au><au>Farid, Nr</au><au>Siffert, W</au><au>Schmid, Kw</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The C allele of the GNB3 C825T polymorphism of the G protein beta 3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours</atitle><jtitle>The Journal of pathology</jtitle><date>2007-01-01</date><risdate>2007</risdate><volume>211</volume><issue>1</issue><spage>60</spage><epage>66</epage><pages>60-66</pages><issn>0022-3417</issn><abstract>Carriers of the C allele of the common C825T polymorphism in the GNB3 gene of the G protein have been associated with the development of follicular thyroid adenomas. Since the C allele of this polymorphism is related to a lower signalling capacity, it was speculated whether the C825T polymorphism may play a particular role in oncocytic thyroid tumours, which are recognized for their reduced ability to synthesize thyroid-specific proteins and hormones, although they possess an intact thyroid-stimulating hormone receptor-adenylyl cyclase system. Using pyrosequencing, both the genotype distribution and the allele frequency of the C825T polymorphism were investigated in a series of 104 patients with oncocytic thyroid tumours of follicular cell origin [58 adenomas, 41 follicular thyroid carcinomas (FTCs), and five papillary thyroid carcinomas (PTCs)]; the results were compared with those obtained from 321 age and gender- matched healthy blood donors and a series of 327 non-oncocytic thyroid tumours of follicular cell origin (119 adenomas, 80 FTCs, and 186 PTCs). Analysis of the genotype distribution (comparing oncocytic with non-oncocytic tumours of the present series) revealed a significantly increased odds ratio (OR) for CC versus TT (OR = 4.22; p = 0.011) and CC versus CT (OR = 1.62; p = 0.049) carriers to develop an oncocytic thyroid tumour; ORs to develop an oncocytic thyroid tumour were also increased comparing the genotype distribution between the group of oncocytic tumours and healthy controls for CC versus TT (OR = 3.73; p = 0.017) and CC versus all T carriers (OR = 1.56; p = 0.034). Oncocytic thyroid tumours as a group showed a statistically significant increase of the C-allele frequency when compared with all non-oncocytic tumours (p = 0.0039) as well as healthy blood donors (p = 0.017). The results strongly suggest that the C allele of the GNB3 C825T polymorphism of the G protein beta 3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours. This polymorphism may thus be considered a (co)factor favouring the development of oncocytic thyroid tumours, although the biological mechanism(s) underlying this association remain obscure.</abstract><doi>10.1002/path.2084</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3417 |
ispartof | The Journal of pathology, 2007-01, Vol.211 (1), p.60-66 |
issn | 0022-3417 |
language | eng |
recordid | cdi_proquest_miscellaneous_19498157 |
source | Access via Wiley Online Library |
title | The C allele of the GNB3 C825T polymorphism of the G protein beta 3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T15%3A18%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20C%20allele%20of%20the%20GNB3%20C825T%20polymorphism%20of%20the%20G%20protein%20beta%203-subunit%20is%20associated%20with%20an%20increased%20risk%20for%20the%20development%20of%20oncocytic%20thyroid%20tumours&rft.jtitle=The%20Journal%20of%20pathology&rft.au=Sheu,%20S-Y&rft.date=2007-01-01&rft.volume=211&rft.issue=1&rft.spage=60&rft.epage=66&rft.pages=60-66&rft.issn=0022-3417&rft_id=info:doi/10.1002/path.2084&rft_dat=%3Cproquest%3E19498157%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19498157&rft_id=info:pmid/&rfr_iscdi=true |